Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey
Author:
Publisher
Wiley
Subject
Rheumatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.20674/fullpdf
Reference23 articles.
1. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis;Saag;Arthritis Rheum,2008
2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs;Smolen;Ann Rheum Dis,2010
3. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study;Gibofsky;Curr Med Res Opin,2006
4. Agency for Healthcare Research and Quality 2010 http://www.qualitymeasures.ahrq.gov/content.aspx?id=33606&search=rheumatoid+arth
5. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis;Salliot;Ann Rheum Dis,2011
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Interpreting and Addressing Racialized Inequities in Rheumatic Disease Care and Outcomes;Arthritis Care & Research;2024-05-30
2. Racialized Inequities in Knee Arthroplasty Receipt After Osteoarthritis Diagnosis in the US Military Health System;Arthritis Care & Research;2024-02-05
3. Disease-Modifying Antirheumatic Drug Use and Its Effect on Long-term Opioid Use in Patients With Rheumatoid Arthritis;JCR: Journal of Clinical Rheumatology;2023-04-26
4. Racial and Ethnic Differences in a Biochemical Marker of Rheumatoid Arthritis Disease Activity;ACR Open Rheumatology;2023-02-08
5. Social, political, and economic determinants of access to biologics: A scoping review of structural determinants in the clinical disparities literature;Research in Social and Administrative Pharmacy;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3